Summit Corp. Plc
| London Stock Exchange: SUMM
Summit Corp. Plc is a drug discovery company, which discovers and develops novel drugs for major areas of unmet medical need. Its focus is on two therapy areas: the fatal muscle wasting disease Duchenne Muscular Dystrophy and the infectious disease caused by the bacteria C. difficile. Summit was founded by Stephen Graham Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.